Form 4: Zimmer Biomet Executive Wilfred van Zuilen Reports RSU Vesting and Tax-Related Share Disposition

Zimmer Biomet Holdings, Inc. Group President, EMEA, Wilfred van Zuilen, reported the vesting of 2,631 restricted stock units and the subsequent disposition of 692 shares to cover tax obligations.

Summary

• Wilfred van Zuilen, Group President, EMEA, at Zimmer Biomet Holdings, Inc. (ZBH), reported transactions related to his equity holdings.
• On July 1, 2025, 2,631 restricted stock units (RSUs) vested, converting into an equal number of common shares.
• Concurrently, 692 shares of common stock were disposed of at a price of $92.77 per share to satisfy tax withholding obligations associated with the RSU vesting.
• Following these transactions, Wilfred van Zuilen directly beneficially owns 21,473 shares of Zimmer Biomet common stock.
• All 2,631 previously held Restricted Stock Units are now fully vested and converted, resulting in a zero balance of RSUs.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates the vesting of executive equity, which aligns management's interests with shareholders. The share disposition is for tax purposes, a routine event, and not a discretionary sale, thus not negative.

Positives

• Vesting of 2,631 restricted stock units indicates the fulfillment of equity compensation, aligning executive interests with shareholder value.
• The executive continues to hold a significant number of shares (21,473), demonstrating ongoing commitment to the company.

Negatives

• 692 shares were disposed of, though this was specifically for tax withholding purposes and not a discretionary sale.

Future Outlook

NA

Industry Context

This Form 4 filing reflects a routine equity compensation event for a senior executive at a major medical technology company. The vesting of restricted stock units and subsequent tax-related share disposition are common practices in executive compensation structures across the healthcare and med-tech industries, designed to align executive incentives with long-term company performance.

Stakeholder Impact

• Shareholders: The vesting and retention of a significant number of shares by a key executive can be seen positively as it aligns management's interests with shareholder value. The tax-related sale is a standard part of equity compensation.
• Employees: No direct impact on general employees.
• Customers/Suppliers/Creditors: No direct impact.

Key Dates

Keywords

Zimmer Biomet Holdings, ZBH, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Executive Compensation, Share Disposition, Tax Withholding, Wilfred van Zuilen, Corporate Governance